Gilead Sciences EuroCharity's RSS for Gilead Sciences en 2010 11th Tuesday of May 2021 07:57:44 AM 11th Tuesday of May 2021 07:57:44 AM en 2010 Logo Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach Gilead Will Provide $5 Million in Grant Funding to Wake Forest Over 3 Years as Part of the Gilead COMPASS Initiative ® in the Southern United States 2021-02-23 13:02:26 15846 2010-03-23T15:57:28Z Gilead: Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research Research Veteran Brings More than 30 Years of Industry and NIH Experience to Kite Leadership Team 2021-01-26 12:01:09 15799 2010-03-23T15:57:28Z European Commission Grants Marketing Authorization for Jyseleca® (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis 2020-09-28 16:09:39 15638 2010-03-23T15:57:28Z An Open Letter from Daniel O’Day, Chairman & CEO, Gilead Sciences As with all our actions on remdesivir, we approached this with the aim of helping as many patients as possible 2020-09-28 16:09:07 15637 2010-03-23T15:57:28Z Gilead Ramps Up Cancer Focus With $21 Billion Immunomedics Deal Another big bet by Gilead that an innovative tumor-fighting drug can boost its fortunes 2020-09-14 12:09:02 15624 2010-03-23T15:57:28Z